Assessment of mortality risk in elderly patients after proximal femoral fracture

Orthopedics. 2014 Feb;37(2):e194-200. doi: 10.3928/01477447-20140124-25.

Abstract

Mortality after hip fracture is a major problem in the Western world, but its mechanisms remain uncertain. This study assessed the 2-year mortality rate after hip fracture in elderly patients by including hospital factors (eg, intervention type, surgical delay), underlying health conditions, and, for a subset, lifestyle factors (eg, body mass index, smoking, alcohol). A total of 828 patients (183 men) 70 to 99 years old experiencing a hip fracture in 2009 in the province of Varese were included in the study. The risk factors for death were assessed through Kaplan-Meier analysis and Cox proportional hazards analysis. Hip fracture incidence per 1000 persons was higher in women (8.4 vs 3.7 in men) and in elderly patients (12.4 for 85-99 years vs 4.4 for 70-84 years). The mortality rate after 1, 6, 12, and 24 months was 4.7%, 16%, 20.7%, and 30.4%, respectively. For the province of Varese, sex (hazard ratio, 0.39 for women), age group (hazard ratio, 2.2 for 85-99 years), and Charlson Comorbidity Index score (hazard ratio, 2.06 for score greater than 1) were found to be statistically significant. The 2-year mortality rate in hip fractures is associated with sex, age, and comorbidities. Male sex, age older than 85 years, and Charlson Comorbidity Index score greater than 1 are associated with a higher risk. Surgical delay was significant in the Kaplan-Meier survival time analysis but not in the Cox hazard analysis, suggesting that early surgery reduces risk in patients with numerous comorbidities.

MeSH terms

  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Female
  • Femoral Neck Fractures / mortality*
  • Femoral Neck Fractures / surgery*
  • Hospital Mortality
  • Humans
  • Italy / epidemiology
  • Length of Stay
  • Male
  • Marital Status / statistics & numerical data
  • Retrospective Studies
  • Risk Factors
  • Sex Distribution
  • Survival Rate
  • Treatment Outcome
  • Waiting Lists / mortality*